Inhibition of HIV‐1 Replication by Isoxazolidine and Isoxazole Sulfonamides
Open Access
- 24 March 2010
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 75 (5), 461-474
- https://doi.org/10.1111/j.1747-0285.2010.00956.x
Abstract
Targeting host factors is a complementary strategy for the development of new antiviral drugs. We screened a library of isoxazolidine and isoxazole sulfonamides and found four compounds that inhibited HIV-1 infection in human CD4+ lymphocytic T cells with no toxicity at IC(90) concentrations. Structure-activity relationship showed that benzyl sulfonamides and a halo-substituted aromatic ring on the heterocycle scaffold were critical for antiretroviral activity. The size and position of the incorporated halogen had a marked effect on the antiretroviral activity. The sulfonamide derivatives had no significant effect on HIV-1 entry, reverse transcription and integration but impaired a step necessary for activation of viral gene expression. This step was Tat-independent, strongly suggesting that the target is a cell factor. A virus partially resistant to the least potent compounds could be selected but could not be propagated in the long term, consistent with the possibility that HIV-1 may be less likely to develop resistance against drugs targeting some host factors. Here, we provide evidence that novel synthetic methods can be applied to develop small molecules with antiretroviral activity that target host factors important for HIV-1 replication.Keywords
This publication has 38 references indexed in Scilit:
- 3,5-Isoxazoles from α-bromo-pentafluorophenyl vinylsulfonates: Synthesis of sulfonates and sulfonamidesOrganic & Biomolecular Chemistry, 2009
- Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve IndividualsJournal of Virology, 2009
- HIV-1 exploits importin 7 to maximize nuclear import of its DNA genomeRetrovirology, 2009
- The Host Cell Sulfonation Pathway Contributes to Retroviral Infection at a Step Coincident with Provirus EstablishmentPLoS Pathogens, 2008
- Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 ReplicationCell, 2008
- Identification of Host Proteins Required for HIV Infection Through a Functional Genomic ScreenScience, 2008
- A Phenotypic Recessive, Post-Entry Block in Rabbit Cells that Results in Aberrant Trafficking of HIV-1Traffic, 2006
- Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyBMJ, 2005
- Exploring biology with small organic moleculesNature, 2004
- Characterization of Intracellular Reverse Transcription Complexes of Human Immunodeficiency Virus Type 1Journal of Virology, 2001